AWA
FHTX icon

Alta Wealth Advisors’s Foghorn Therapeutics FHTX Stock Holding History

Alta Wealth Advisors’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,032
Closed -$49.1K – 171
2025
Q3 		$49.1K Buy
+10,032
New +$53.2K 0.02% 156
2025
Q2 		– Sell
-15,032
Closed -$54.9K – 125
2025
Q1 		$54.9K Hold
15,032
– – 0.03% 141
2024
Q4 		$71K Hold
15,032
– – 0.03% 132
2024
Q3 		$140K Sell
15,032
-15,000
-50% -$109K 0.06% 132
2024
Q2 		$173K Hold
30,032
– – 0.09% 120
2024
Q1 		$202K Hold
30,032
– – 0.1% 128
2023
Q4 		$194K Buy
+30,032
New +$130K 0.11% 125

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Alta Wealth Advisors's FHTX Position: Q4 2025 in Review

Alta Wealth Advisors sold out of Foghorn Therapeutics (FHTX) in Q4 2025, closing a stake of 10,032 shares — an estimated $49.1K sold.

Alta Wealth Advisors first reported a position in FHTX in Q4 2023 and held it in 7 quarters. The position peaked at $202K in Q1 2024. 93 funds tracked by Wall St. Rank hold FHTX as of Q4 2025.

  • Alta Wealth Advisors reported no remaining Foghorn Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Alta Wealth Advisors sold 10,032 Foghorn Therapeutics shares in Q4 2025, an estimated $49.1K.
  • Alta Wealth Advisors first reported a position in Foghorn Therapeutics in Q4 2023 and held it in 7 quarters.
  • Alta Wealth Advisors's Foghorn Therapeutics position peaked at $202K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q4 2025.

Based on Alta Wealth Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.